01 2Curia Italy S.r.l.
02 1LETCO MEDICAL, LLC
03 1Medisca Inc.
04 1Olon SpA
05 1Professional Compounding Centers of America
06 1Professional Compounding Centers of America dba PCCA
07 1TAPI Czech Industries s.r.o.
08 2Teva Czech Industries s.r.o
01 4DIHYDROERGOTAMINE MESYLATE
02 1Dihydroergotamine
03 3Dihydroergotamine Mesylate
04 2Dihydroergotamine mesylate
01 2Israel
02 1Italy
03 4U.S.A
04 2United Kingdom
05 1Blank
NDC Package Code : 55486-1587
Start Marketing Date : 2012-06-03
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 55486-1599
Start Marketing Date : 2014-12-23
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62991-2858
Start Marketing Date : 2010-10-06
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 38779-0303
Start Marketing Date : 2015-08-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 17337-0061
Start Marketing Date : 2015-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-0295
Start Marketing Date : 2023-03-10
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-1706
Start Marketing Date : 2013-06-27
End Marketing Date : 2026-06-30
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 47848-052
Start Marketing Date : 2016-03-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 47848-006
Start Marketing Date : 2017-11-21
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84644-006
Start Marketing Date : 2024-11-07
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
A Dihydroergotamine Mesylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Dihydroergotamine Mesylate, including repackagers and relabelers. The FDA regulates Dihydroergotamine Mesylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Dihydroergotamine Mesylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Dihydroergotamine Mesylate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Dihydroergotamine Mesylate supplier is an individual or a company that provides Dihydroergotamine Mesylate active pharmaceutical ingredient (API) or Dihydroergotamine Mesylate finished formulations upon request. The Dihydroergotamine Mesylate suppliers may include Dihydroergotamine Mesylate API manufacturers, exporters, distributors and traders.
click here to find a list of Dihydroergotamine Mesylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Dihydroergotamine Mesylate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Dihydroergotamine Mesylate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Dihydroergotamine Mesylate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Dihydroergotamine Mesylate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Dihydroergotamine Mesylate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Dihydroergotamine Mesylate suppliers with NDC on PharmaCompass.
We have 6 companies offering Dihydroergotamine Mesylate
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
